Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

IDELALISIB for B-cell lymphoma: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 1,240 adverse event reports in the FDA FAERS database where IDELALISIB was used for B-cell lymphoma.

Most Reported Side Effects for IDELALISIB

Side Effect Reports % Deaths Hosp.
Disease progression 1,204 17.6% 139 130
Death 779 11.4% 779 117
Diarrhoea 752 11.0% 87 510
Off label use 548 8.0% 85 159
Pneumonia 426 6.2% 140 311
Pyrexia 371 5.4% 44 290
Drug ineffective 294 4.3% 62 63
Fatigue 284 4.1% 29 132
Dehydration 242 3.5% 22 212
Dyspnoea 206 3.0% 41 143
Neutropenia 204 3.0% 47 100
Colitis 201 2.9% 41 133
Pneumonitis 199 2.9% 57 133
Asthenia 193 2.8% 22 138
Rash 168 2.5% 27 63

Other Indications for IDELALISIB

Chronic lymphocytic leukaemia (3,537) Product used for unknown indication (551) Non-hodgkin's lymphoma (373) Lymphoma (301) Follicular lymphoma (200) Non-hodgkin's lymphoma unspecified histology indolent (164) Waldenstrom's macroglobulinaemia (88) Leukaemia (74) Diffuse large b-cell lymphoma (66) B-cell small lymphocytic lymphoma (65)

Other Drugs Used for B-cell lymphoma

RITUXIMAB (7,811) CYCLOPHOSPHAMIDE (4,766) VINCRISTINE (4,346) DOXORUBICIN (3,947) LENALIDOMIDE (3,474) PREDNISONE (2,561) BENDAMUSTINE (1,668) PREDNISOLONE (1,489) ETOPOSIDE (1,268) OBINUTUZUMAB (1,200)

Related Pages

IDELALISIB Full Profile All B-cell lymphoma Drugs IDELALISIB Demographics IDELALISIB Timeline